Request Demo
Last update 13 May 2026
BMS-986482
Last update 13 May 2026
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms BMS-986482 |
Action degraders |
Mechanism IKZF1 degraders(DNA-binding protein Ikaros degraders), IKZF2 degraders(Zinc finger protein helios degraders), IKZF3 degraders(Zinc finger protein Aiolos degraders) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC21H19FN4O4 |
InChIKeyPKEKMIKJWMHBLO-UHFFFAOYSA-N |
CAS Registry3062993-48-7 |
Related
1
Clinical Trials associated with BMS-986482NCT06697197
A Phase 1/2 Study of BMS-986482 as Monotherapy or Combination Therapy in Participants With Advanced Solid Tumors
100 Clinical Results associated with BMS-986482
Login to view more data
100 Translational Medicine associated with BMS-986482
Login to view more data
100 Patents (Medical) associated with BMS-986482
Login to view more data
100 Deals associated with BMS-986482
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 2 | United States | 17 Feb 2025 | |
| Advanced Malignant Solid Neoplasm | Phase 2 | Belgium | 17 Feb 2025 | |
| Advanced Malignant Solid Neoplasm | Phase 2 | Denmark | 17 Feb 2025 | |
| Advanced Malignant Solid Neoplasm | Phase 2 | France | 17 Feb 2025 | |
| Advanced Malignant Solid Neoplasm | Phase 2 | Greece | 17 Feb 2025 | |
| Advanced Malignant Solid Neoplasm | Phase 2 | Italy | 17 Feb 2025 | |
| Advanced Malignant Solid Neoplasm | Phase 2 | Netherlands | 17 Feb 2025 | |
| Advanced Malignant Solid Neoplasm | Phase 2 | Spain | 17 Feb 2025 | |
| Advanced Malignant Solid Neoplasm | Phase 2 | Sweden | 17 Feb 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free